MedPath

LANEIGE HYDRO UV DEFENSE EX

LANEIGE HYDRO UV DEFENSE EX

Approved
DIN Number

02545403

Drug Class

Human

Market Date

Jul 7, 2024

Company
HC

AMOREPACIFIC CORPORATION

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02545403
AIG Number0451521128
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:80.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

AVOBENZONEActive
Strength: 2.5 % / W/W
Monograph: AVOBENZONE
HOMOSALATEActive
Strength: 7 % / W/W
Monograph: HOMOSALATE
OCTISALATEActive
Strength: 4.5 % / W/W
Monograph: OCTISALATE
OCTOCRYLENEActive
Strength: 9 % / W/W
Monograph: OCTOCRYLENE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.